ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Yoji Taki

Department of Urology, Toyooka Hospital, Toyooka City, Hyogo, Japan

Biography

Yoji Taki is currently working as a Professor in the Department of Urology, Toyooka Hospital, Toyooka City, Hyogo, Japan. The author's research interests include Clinical Pathology, Histopathology, Hemato Pathology, Surgical Pathology, Diagnosis. The author is serving as an editorial member and reviewer of several international reputed journals. The author has successfully completed his administrative responsibilities. The author has authorized many research articles/books related to Clinical Pathology, Experimental Pathology.

Publications

A Case of Exophytic Type 2A Papillary Renal Cell Carcinoma with Massive Necrosis

Most renal cell carcinomas (RCCs) are clear cell RCCs, the second most common being papillary RCCs (PRCCs). PRCCs are sub classified as type 1, type 2A, type 2B and mixed type. Pure type 2A PRCCs are estimated to account for only approximately 1-2% of malignant tumors of the kidney. In this paper, we show a case of an exophytic type 2A PRCC with ma... Read More»

Toshihiro Magaribuchi, Yasushi Adachi, Naoto Kuroda, Toru Sakatani, Yoji Taki, Ming Li and Susumu Ikehara

Commentary: J Clin Exp Pathol 2015, 6: 263

DOI: 10.4172/2161-0681.1000263

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top